Cyclosporine NDC 60505-0134

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-0134Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-0134Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-0134-0	60505013400	30 CAPSULE, GELATIN COATED in 1 BOTTLE (60505-0134-0)Marketed from May 29, 2002

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cyclosporine
Generic name (nonproprietary): cyclosporine
Active ingredients: Cyclosporine — 100 mg/1
Dosage form: Capsule, Gelatin coated
Route: Oral
Labeler: Apotex Corp.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065040
Marketing start: May 29, 2002
Listing expires: Dec 31, 2027
Other FDA classes: Calcineurin Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 60505-0134_561ed7a8-f342-f4fe-ce36-998d87c33e7fSPL ID 561ed7a8-f342-f4fe-ce36-998d87c33e7fSPL set ID bfca7088-fe93-abb9-3ec3-e6f5710a69c6RxCUI 197553, 328160UNII 83HN0GTJ6D
Pharmacologic class: Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505013400 followed by a unit qualifier and the quantity

Package 60505-0134-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 22, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cyclosporine capsules, (NON-MODIFIED), in combination with adrenal corticosteroids, are indicated for the: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Treatment of chronic rejection in patients previously treated with other immunosuppressive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065040

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065040
Product	Strength	Form · route	Labeler	Product NDC
Cyclosporine	Cyclosporine 25 mg/1	Capsule, Gelatin coatedOral	American Health Packaging	68084-879
Cyclosporine	Cyclosporine 100 mg/1	Capsule, Gelatin coatedOral	American Health Packaging	68084-921
Cyclosporine	Cyclosporine 25 mg/1	Capsule, Gelatin coatedOral	Apotex Corp.	60505-0133